Skip to main

UK Patent Ruling Boosts Pfizer in Global RSV Vaccine Market

Share:

A UK court invalidated two GSK patents in a Pfizer dispute, reinforcing Pfizer’s RSV vaccine position. This ruling may influence ongoing global legal battles, particularly outside the U.S.

Learn More